Wolverine Trading, LLC Glaukos Corp Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

A detailed history of Wolverine Trading, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 6,119 shares of GKOS stock, worth $937,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,119

Previous 1,747 250.26%

Holding current value

$937,430

Previous $227,000 303.96%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $552,708 - $667,473	4,372 Added 250.26%	6,119 $917,000
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $198,494 - $236,526	1,747 New	1,747 $227,000
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $67,923 - $97,110	1,141 Added 19.21%	7,081 $562,000
Q3 2023 Nov 15, 2023	BUY	$69.23 - $79.09 $141,575 - $161,739	2,045 Added 52.5%	5,940 $446,000
Q2 2023 Aug 23, 2023	BUY	$45.44 - $71.21 $176,988 - $277,362	3,895 New	3,895 $277,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $704,192 - $879,338	15,034 Added 302.37%	20,006 $1.07 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $216,968 - $396,904	-6,224 Reduced 55.59%	4,972 $227,000
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $106,214 - $138,536	2,396 Added 27.23%	11,196 $642,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $71,277 - $100,872	-1,770 Reduced 16.75%	8,800 $403,000
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $125,547 - $222,956	2,647 Added 33.41%	10,570 $516,000
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $294,973 - $403,835	7,923 New	7,923 $404,000
Q2 2019 Aug 20, 2019	SELL	$63.59 - $78.71 $181,167 - $224,244	-2,849 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $179,807 - $285,353	-3,543 Reduced 55.43%	2,849 $223,000
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $243,726 - $437,021	6,392 New	6,392 $415,000

Others Institutions Holding GKOS

# of Institutions

359

Shares Held

49.7M

Call Options Held

227K

Put Options Held

444K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Glaukos Corp Transaction History